AOD9604 is a laboratory-made fragment of human growth hormone that researchers study to understand how specific parts of this hormone influence fat metabolism
References Bendotti, G., Montefusco, L., Lunati, M
Instead of that tongue-twister of a name, we call these medications GLP-1s for short
de novo lipogenesis, along with downregulating enzymes linked to lipid synthesis, such as ACC and FAS ( in vitro experiment demonstrated that GLP-1RA induces the phosphorylation of Akt, PDK-1, and PKC-, which are key proteins involved in the insulin signaling pathway
Current clinical trials and future research directions As of early 2026, no active clinical trials are specifically investigating tirzepatide for autoimmune disease treatment